Please note that we have published slides to accompany the earnings release ... you joining us and your continued interest in the QVC Group. Q1 was a challenging quarter. We're operating in ...

2025. Leverage Ratio: 3.7 times, excluding Cornerstone, compared to a maximum covenant threshold of 4.5 times. Customer Count Decline: QxH customer count down 10%, QVC International customer count ...

QVC Group Inc. (QVCGA ... Total revenue declined by 10% in Q1 2025. Stock price dropped 18.58% in regular trading and 28.4% in aftermarket. Strategic partnerships with TikTok and American Airlines ...

Please note that we have published slides to accompany the earnings release. On today's call ... We appreciate you joining us and your continued interest in the QVC Group. Q1 was a challenging quarter ...

Total revenue declined by 10% in Q1 2025. Stock price dropped 18.58% in regular trading ... High net debt of $4.7 billion, with a leverage ratio of 3.7x. Following the earnings announcement, QVC Group ...

QVC Group Inc. (QVCGA) on Wednesday reported a loss of $100 million in its first quarter. On a per-share basis, the ...

The following slide deck was published by QVC Group Inc. in conjunction with their 2025 Q1 earnings call.

Adaptimmune Therapeutics plc (NASDAQ: ADAP) Q1 2025 Earnings Call Transcript May 13, 2025 Adaptimmune Therapeutics plc beats earnings expectations. Reported EPS is $-0.03086, expectations were $-0.18.

Q1 2025 Earnings Call Transcript May 21, 2025 Operator: Thank you for standing by, and welcome to the iQIYI’s First Quarter ...